Mark Daniel DeBoer

Mark Daniel DeBoer, MD, is an Associate Professor of Pediatrics at the University of Virginia School of Medicine, specializing in Pediatric Endocrinology. He holds a dual clinical and research role, focusing on automated diabetes technology, metabolic syndrome, and global pediatric growth barriers. His clinical practice spans UVA Health and affiliated locations, with primary expertise in Type 1 diabetes management and pediatric endocrinology. Dr. DeBoer completed his medical degree at the University of Arizona, residency at UVA, and fellowship at Oregon Health & Science University, joining UVA's faculty in 2007.

Research interests include artificial pancreas systems, puberty timing in chronic disease, and global health interventions in resource-poor settings. He leads studies on hybrid closed-loop insulin delivery systems and their long-term efficacy in pediatric populations, as well as international collaborations like the IMiC Consortium analyzing human milk composition's impact on growth. His work also explores obesity's hormonal effects in adolescents and the interplay between metabolic syndrome severity and public health outcomes.

Key contributions include pioneering closed-loop technology trials in young children and demonstrating sustained glycemic improvements during puberty. His studies frequently address global health disparities, such as seasonal malnutrition's impact on Tanzanian children's development. Dr. DeBoer's clinical expertise includes managing diabetes technology adoption challenges and optimizing insulin regimens for pediatric patients.